SCOPUS 정보 검색 플랫폼

Volumn 64, Issue 6-7, 1999, Pages 527-534

Potential role of muscarinic receptors in schizophrenia

(16) Bymaster, Frank P a Shannon, Harlan E a Rasmussen, Kurt a DeLapp, Neil W a Ward, John S a Calligaro, David O a Mitch, Charles H a Whitesitt, Celia a Ludvigsen, Thomas S b Sheardown, Malcolm b Swedberg, Michael b Rasmussen, Thøger b Olesen, Preben H b Jeppesen, Lone b Sauerberg, Per b Fink Jensen, Anders b

a ELI LILLY AND COMPANY (United States)

b NOVO NORDISK A S (Denmark)

Author keywords

Antipsychotic agent; Dopamine; Muscarinic agonist; Muscarinic receptor; Schizophrenia

Indexed keywords

6 (3 PROPYLTHIO 1,2,5 THIADIAZOL 4 YL) 1 AZABICYCLO[3.2.1]OCTANE; APOMORPHINE; BICYCLO[3.2.1]OCTANE DERIVATIVE; DEXAMPHETAMINE; DOPAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBTYPE; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AVOIDANCE BEHAVIOR; CLIMBING; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG SELECTIVITY; EXTRAPYRAMIDAL SYMPTOM; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BICYCLO COMPOUNDS; BINDING, COMPETITIVE; CATALEPSY; CHO CELLS; CRICETINAE; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, MUSCARINIC; SCHIZOPHRENIA; SECOND MESSENGER SYSTEMS; THIADIAZOLES;

ANIMALIA;

EID: 0033534710 PISSN: 00243205 EISSN: None Source Type: Journal
DOI: 10.1016/S0024-3205(98)00597-9 Document Type: Conference Paper

Times cited : (57)

References (28)

1
- 0031408442
- P. Willner, Int. Clin. Psychopharmacology 12 297-308 (1997)
- (1997) Int. Clin. Psychopharmacology , vol.12 , pp. 297-308
- Willner, P.¹

2
- 0028919572
- D. Pickar, Lancet 345 557-562 (1995)
- (1995) Lancet , vol.345 , pp. 557-562
- Pickar, D.¹

3
- 0026576739
- M.-M. Mesulam, L.B. Hersh, D.C. Mash and C. Geula, J. Comp. Neurol. 318 316-328 (1992)
- (1992) J. Comp. Neurol. , vol.318 , pp. 316-328
- Mesulam, M.-M.¹ Hersh, L.B.² Mash, D.C.³ Geula, C.⁴

4
- 0028924664
- D.D. Flynn, G. Ferrari-Dileo, D.C. Mash and A.I. Levey, J. Neurochem. 64 1888-1891 (1995)
- (1995) J. Neurochem. , vol.64 , pp. 1888-1891
- Flynn, D.D.¹ Ferrari-Dileo, G.² Mash, D.C.³ Levey, A.I.⁴

5
- 0030467247
- A.I. Levey, Proc. Natl. Acad. Sci. USA 93 13541-13546 (1996)
- (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 13541-13546
- Levey, A.I.¹

6
- 0025130727
- D.M. Weiner, A.I. Levey and M.R. Brann, Proc. Natl. Acad. Sci. USA 87 7050-7054 (1990)
- (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 7050-7054
- Weiner, D.M.¹ Levey, A.I.² Brann, M.R.³

7
- 0026756764
- V. Bernard, E. Normand and B. Bloch, J. Neurosci. 12 3591-3600 (1992)
- (1992) J. Neurosci. , vol.12 , pp. 3591-3600
- Bernard, V.¹ Normand, E.² Bloch, B.³

8
- 0022630287
- F.P. Bymaster, L.R. Reid, C.L. Nichols, E.C. Kornfeld and D.T. Wong, Life Sci. 38 317-322 (1986)
- (1986) Life Sci. , vol.38 , pp. 317-322
- Bymaster, F.P.¹ Reid, L.R.² Nichols, C.L.³ Kornfeld, E.C.⁴ Wong, D.T.⁵

9
- 0028181720
- F.P. Bymaster, D.T. Wong, C.H. Mitch, J.S. Ward, D.O. Calligaro, D.D. Schoepp, H.E. Shannon, M.J. Sheardown, P.H. Olesen, P.D. Suzdak, M.D.B. Swedberg and P Sauerberg, J. Pharmacol. Exp. Ther. 269 282 289 (1994)
- (1994) J. Pharmacol. Exp. Ther. , vol.269 , pp. 282289
- Bymaster, F.P.¹ Wong, D.T.² Mitch, C.H.³ Ward, J.S.⁴ Calligaro, D.O.⁵ Schoepp, D.D.⁶ Shannon, H.E.⁷ Sheardown, M.J.⁸ Olesen, P.H.⁹ Suzdak, P.D.¹⁰ Swedberg, M.D.B.¹¹ Sauerberg, P.¹²

10
- 0025270550
- M.G. Lacey, P. Calabresi and R.A. North. J. Pharmacol. Exp. Ther. 253 395-400 (1991).
- (1991) J. Pharmacol. Exp. Ther. , vol.253 , pp. 395-400
- Lacey, M.G.¹ Calabresi, P.² North, R.A.³

11
- 0029348250
- E.K. Perry and R.H. Perry, Brain and Cognition 28 240-258 (1995)
- (1995) Brain and Cognition , vol.28 , pp. 240-258
- Perry, E.K.¹ Perry, R.H.²

12
- 84981878828
- C.C. Pfeifer and E.H. Jenny, Ann. NY. Acad. Sci. 66 753-764 (1975).
- (1975) Ann. NY. Acad. Sci. , vol.66 , pp. 753-764
- Pfeifer, C.C.¹ Jenny, E.H.²

13
- 0015804129
- R. Rosenthal and L.B. Bigelow, Compr. Psychiatry 14 489-494 (1973)
- (1973) Compr. Psychiatry , vol.14 , pp. 489-494
- Rosenthal, R.¹ Bigelow, L.B.²

14
- 0015819458
- D.S. Janowsky, M.K. El-Yousef, J.M. Davis and H.J. Sekere, Am. J. Psychiatry 130 1370-1376 (1973).
- (1973) Am. J. Psychiatry , vol.130 , pp. 1370-1376
- Janowsky, D.S.¹ El-Yousef, M.K.² Davis, J.M.³ Sekere, H.J.⁴

15
- 0019521227
- P. Edelstein, J.R. Schultz, J. Hirschowitz, D.R. Kanter and D.L. Garver, Am. J. Psychiatry 138 1078-1081 (1981).
- (1981) Am. J. Psychiatry , vol.138 , pp. 1078-1081
- Edelstein, P.¹ Schultz, J.R.² Hirschowitz, J.³ Kanter, D.R.⁴ Garver, D.L.⁵

16
- 0029967523
- K.E. White and J.L. Cummings, Compr. Psychiatry 37 188-195 (1996).
- (1996) Compr. Psychiatry , vol.37 , pp. 188-195
- White, K.E.¹ Cummings, J.L.²

17
- 0030902127
- N.C. Bodick, W.W. Offen, A.I. Levey, N.R. Cutler, S.G. Gauthier, A. Satlin, H.E. Shannon, G.D. Tollefson, K. Rasmussen, F.P. Bymaster, D.J. Hurley, W.Z. Potter, S.M. Paul, Arch. Neurology 54 465- 473 (1997).
- (1997) Arch. Neurology , vol.54 , pp. 465-473
- Bodick, N.C.¹ Offen, W.W.² Levey, A.I.³ Cutler, N.R.⁴ Gauthier, S.G.⁵ Satlin, A.⁶ Shannon, H.E.⁷ Tollefson, G.D.⁸ Rasmussen, K.⁹ Bymaster, F.P.¹⁰ Hurley, D.J.¹¹ Potter, W.Z.¹² Paul, S.M.¹³

18
- 0028914212
- J.S. Yeomans, Neuropsychopharmacology 12 3-16 (1995)
- (1995) Neuropsychopharmacology , vol.12 , pp. 3-16
- Yeomans, J.S.¹

19
- 0024321406
- R. Tandon and J.F. Greden, Arch. Gen. Psychiatry 46 745-753 (1989).
- (1989) Arch. Gen. Psychiatry , vol.46 , pp. 745-753
- Tandon, R.¹ Greden, J.F.²

20
- 84889202638
- in press
- F.P. Bymaster, H.E. Shannon, K. Rasmussen, N.W. DeLapp, C.H. Mitch, J.S. Ward, D.O. Calligaro, T.S. Ludvigsen, M.J. Sheardown, P.H. Olesen, M.D.B. Swedberg, P. Sauerberg and A. Fink-Jensen, Eur J. Pharmacol., in press (1998)
- (1998) Eur J. Pharmacol.
- Bymaster, F.P.¹ Shannon, H.E.² Rasmussen, K.³ DeLapp, N.W.⁴ Mitch, C.H.⁵ Ward, J.S.⁶ Calligaro, D.O.⁷ Ludvigsen, T.S.⁸ Sheardown, M.J.⁹ Olesen, P.H.¹⁰ Swedberg, M.D.B.¹¹ Sauerberg, P.¹² Fink-Jensen, A.¹³

21
- 0028344181
- H.E. Shannon, F.P. Bymaster, D.O. Calligaro, B. Greenwood, C.H. Mitch, B.D. Sawyer, J.S. Ward, D.T. Wong, P.H. Olesen, M.J. Sheardown, M.D.B. Swedberg, P.D. Suzdak and P. Sauerberg, J. Pharmacol. Exp. Ther. 269 271-281 (1994)
- (1994) J. Pharmacol. Exp. Ther. , vol.269 , pp. 271-281
- Shannon, H.E.¹ Bymaster, F.P.² Calligaro, D.O.³ Greenwood, B.⁴ Mitch, C.H.⁵ Sawyer, B.D.⁶ Ward, J.S.⁷ Wong, D.T.⁸ Olesen, P.H.⁹ Sheardown, M.J.¹⁰ Swedberg, M.D.B.¹¹ Suzdak, P.D.¹² Sauerberg, P.¹³

22
- 0019943797
- J. Arndt, Acta Pharmacol. Et Toxicol. 51 321-329 (1982).
- (1982) Acta Pharmacol. Et Toxicol. , vol.51 , pp. 321-329
- Arndt, J.¹

23
- 0013478566
- R.K. Chalmers and C.K. Erickson, Psychopharmacologia 6 31-41 (1964)
- (1964) Psychopharmacologia , vol.6 , pp. 31-41
- Chalmers, R.K.¹ Erickson, C.K.²

24
- 0023906887
- N.A. Moore and M.S. Axton, Psychopharmacology 94 263-266 (1988).
- (1988) Psychopharmacology , vol.94 , pp. 263-266
- Moore, N.A.¹ Axton, M.S.²

25
- 0028170769
- A. Fink-Jensen and P. Kristensen, Neurosci. Lett. 182 115-118 (1994).
- (1994) Neurosci. Lett. , vol.182 , pp. 115-118
- Fink-Jensen, A.¹ Kristensen, P.²

26
- 0020576408
- L.A. Chiodo and B.S. Bunney, J. Neurosci. 8 1607-1619 (1983).
- (1983) J. Neurosci. , vol.8 , pp. 1607-1619
- Chiodo, L.A.¹ Bunney, B.S.²

27
- 0030040463
- M.E. Stockton and K. Rasmussen, Neuropsychopharmacology 14 97-104 (1996).
- (1996) Neuropsychopharmacology , vol.14 , pp. 97-104
- Stockton, M.E.¹ Rasmussen, K.²

28
- 0028222321
- G. Di Chiara, M. Morelli, and S. Consolo, Trends in Neurosciences 17 228-233 (1994)
- (1994) Trends in Neurosciences , vol.17 , pp. 228-233
- Di Chiara, G.¹ Morelli, M.² Consolo, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.